Taking stock of photographic technology: Fujifilm finds new uses.
18.7%Imaging share of group revenue (site calculation)
¥1.099tnHealthcare revenue
12 / 16 equivalentU.S. bioreactor-capacity equivalent sold before operation (including informal agreements)
What emerges
See the company through the numbers →Fujifilm combines technologies developed for photography with acquired businesses and manufacturing capacity. Alongside office and printing products, medical systems, photography and semiconductor materials, its Bio CDMO develops and manufactures drugs for pharmaceutical customers. The 12/16 U.S. figure describes capacity covered by contracts and informal agreements on planned manufacturing volumes, rather than sales of manufacturing equipment.